Clinical significance of interleukin-36 alpha and gamma in systemic lupus erythematosus patients: Potential relation to disease activity and subclinical arthritis

Lahita, 2016, The immunoendocrinology of systemic lupus erythematosus, ClinImmunol, 172, 98 Abdel-Magied, 2019, Diagnostic potential of ultrasound in systemic lupus erythematosus patients with joint involvement Relation to anticycliccitrullinatedpeptide (anti-CCP), disease activity and functional status, EgyptianRheumatologist, 44, 225 Cojocaru, 2011, Manifestations of systemic lupus erythematosus, Maedica (Bucur), 6, 330 Wiland, 2010, Musculoskeletal symptoms in systemic lupus erythematosus and their differential diagnosis with rheumatoid arthritis, Ann Acad Med Stetin, 56, 40 Ball, 2012, Lupus arthritis–do we have a clinically useful classification?, Rheumatology (Oxford), 51, 771, 10.1093/rheumatology/ker381 Ozbek, 2003, Delay in the diagnosis of SLE: the importance of arthritis/arthralgia as the initial symptom, Acta Med Okayama, 57, 187 DelleSedie, 2009, Ultrasound imaging for the rheumatologist. XXIV. Sonographic evaluation of wrist and hand joint and tendon involvement in systemic lupus erythematosus, ClinExpRheumatol, 27, 897 Larosa, 2016, Advances in the diagnosis and classification of systemic lupus erythematosus, Expert Rev ClinImmunol, 12, 1309, 10.1080/1744666X.2016.1206470 Dinarello, 2018, Overview of the IL-1 family in innate inflammation and acquired immunity, Immunol Rev, 281, 8, 10.1111/imr.12621 Yuan, 2019, Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases, Front Immunol, 10, 2532, 10.3389/fimmu.2019.02532 Boutet MA, Nerviani A, Lliso-Ribera G, Lucchesi D, Prediletto E, Ghirardi GM, et al Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis. Rheumatology (Oxford).2020;59(4):828-38. Boutet, 2016, Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease, ClinExpImmunol, 184, 159 Vigne, 2011, IL-36R ligands are potent regulators of dendritic and T cells, Blood, 118, 5813, 10.1182/blood-2011-05-356873 Vigne, 2012, IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells, Blood, 120, 3478, 10.1182/blood-2012-06-439026 Keermann, 2015, Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin, J DermatolSci, 80, 150 Ciccia, 2015, Guggino G et al Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome, ClinExpImmunol, 181, 230 Chu, 2015, Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus, Molecules, 20, 19588, 10.3390/molecules201019588 Schmitt, 2017, Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts, Eur J Immunol, 47, 2101, 10.1002/eji.201646788 Magne, 2006, The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes, Arthritis Res Ther, 8, R80, 10.1186/ar1946 Frey S, Derer A, Messbacher ME, Baeten DL, Bugatti S, Montecucco C et al. The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis. 2013;72(9):1569-74.17. Mai, 2018, Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis, IntImmunopharmacol, 58, 103, 10.1016/j.intimp.2018.03.011 Faezi, 2017, Role of anti-CCP in arthritis in patients with systemic lupus erythematosus, Rheumatol Res, 2, 97, 10.22631/rr.2017.69997.1025 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Gladman DD, Ibañ ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol2002;29:288_91. Backhaus, 2001, Guidelines for musculoskeletal ultrasound in rheumatology, Ann Rheum Dis, 60, 641, 10.1136/ard.60.7.641 Wakefield, 2005, Musculoskeletal ultrasound including definitions for ultrasonographic pathology, J Rheumatol, 32, 2485 Naredo, 2013, Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis, Ann Rheum Dis, 72, 1328, 10.1136/annrheumdis-2012-202092 Gheita, 2021, Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint, Lupus, 30, 1526, 10.1177/09612033211014253 Morand, 2020, Trial of anifrolumab in active systemic lupus erythematosus, New Eng J Med, 382, 211, 10.1056/NEJMoa1912196 El-Gazzar, 2017, IL22 in Egyptian SLE patients, could it reflectdisease activity, skin or renal involvement or is itonly an expensive ESR?, Egyptian Rheumatologist, 39, 13, 10.1016/j.ejr.2016.05.001 Chen, 2010, Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity, J ClinImmunol, 30, 221 Wang, 2021, Elevated levels of serum IL-36α in patients with systemic lupus erythematosus, Biomed Rep, 15, 76, 10.3892/br.2021.1452 Carrier, 2011, Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis, J Invest Dermatol, 131, 2428, 10.1038/jid.2011.234 Chi, 2017, IL-36signaling facilitates activation of the NLRP3 inflammasome and IL23/IL17 axis in renal inflammation and fibrosis, J Am SocNephrol, 28, 2022 Ismail, 2018, Serum Levels of Pentraxin3 and Interlukin36α in Patients with Systemic Lupus and their Relation to Disease Activity, The Egyptian J Immunol, 25, 81 Mohamed, 2021, Association of interleukin-36α gene expression in Egyptian patients with systemic lupus erythematosus with organ involvement and disease activity, Egyptian JImmunol, 28, 75, 10.55133/eji.280208 Brodie, 2018, Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity, Front Immunol, 9, 401, 10.3389/fimmu.2018.00401 Majumder, 2021, Elevated urinary IL-36-γ in patients with active lupus nephritis and response to treatment, Lupus, 30, 921, 10.1177/0961203321995246 Zhang, 2014, Serum levels of cytokines in systemic lupus erythematosus, ZRheumatol, 73, 277 Ichii, 2010, Local overexpression of interleukin-1 family, member 6 relates to the development of tubulointerstitial lesions, Lab Invest, 90, 459, 10.1038/labinvest.2009.148